Tenofovir alafenamideMeSH concept

https://www.has-sante.fr/jcms/p_3280914/fr/biktarvy-bictegravir/emtricitabine/tenofovir-alafenamide
2022
false
false
false
France
bictegravir, emtricitabine, tenofovir alafenamide, drug combination
treatment outcome
insurance, health, reimbursement
drug combinations
Emtricitabine
Tenofovir Alafenamide Fumarate
adult
hiv infections
HIV-1
anti-hiv agents
emtricitabine, tenofovir alafenamide and bictegravir
evaluation of the transparency committee
bictegravir
Biktarvy
tenofovir alafenamide
Tenofovir

---
https://www.has-sante.fr/jcms/p_3280914/fr/biktarvy-emtricitabine/-bictegravir-sodique/-tenofovir-alafenamide
2021
false
false
false
France
Emtricitabine
evaluation of the transparency committee
fumarates
Tenofovir
bictegravir
bictegravir
tenofovir alafenamide
tenofovir alafenamide
adenine
Heterocyclic Compounds, 4 or More Rings
bictegravir, emtricitabine, tenofovir alafenamide, drug combination
drug combinations

---
https://www.ema.europa.eu/medicines/human/EPAR/Biktarvy
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Heterocyclic Compounds, 4 or More Rings
Heterocyclic Compounds, 4 or More Rings
Emtricitabine
drug combinations
tenofovir alafenamide
tenofovir alafenamide
drug approval
europe
emtricitabine, tenofovir alafenamide and bictegravir
hiv infections
adult
drug interactions
pregnancy
breast feeding
administration, oral
HIV integrase inhibitors
HIV integrase inhibitors
anti-hiv agents
anti-hiv agents
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug evaluation, preclinical
treatment outcome
bictegravir
bictegravir
Tenofovir
Emtricitabine
adenine
tenofovir alafenamide
tenofovir alafenamide
bictegravir, emtricitabine, tenofovir alafenamide, drug combination

---
https://www.has-sante.fr/portail/jcms/c_2886171/fr/symtuza-darunavir-/cobicistat-/emtricitabine-/tenofovir-alafenamide-association-d-antiviraux
2018
false
false
false
France
French
drug combinations
treatment outcome
anti-hiv agents
hiv infections
adult
adolescent
administration, oral
Cytochrome P-450 CYP3A Inhibitors
hiv protease inhibitors
reverse transcriptase inhibitors
antivirals for systemic use
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
Tenofovir
Darunavir
Cobicistat
tenofovir alafenamide
Emtricitabine
tenofovir alafenamide
adenine
Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00405
2018
false
false
false
Canada
French
drug information
drug combinations
drug approval
canada
bictegravir
bictegravir
emtricitabine, tenofovir alafenamide and bictegravir
Emtricitabine
Emtricitabine
tenofovir alafenamide
tenofovir alafenamide
treatment outcome
hiv infections
anti-hiv agents
anti-hiv agents
reverse transcriptase inhibitors
reverse transcriptase inhibitors
HIV integrase inhibitors
HIV integrase inhibitors
adult
administration, oral
tenofovir alafenamide
tenofovir alafenamide
adenine
adenine
adenine
Heterocyclic Compounds, 4 or More Rings
Heterocyclic Compounds, 4 or More Rings
bictegravir, emtricitabine, tenofovir alafenamide, drug combination
Tenofovir

---
https://www.has-sante.fr/portail/jcms/c_2873692/fr/biktarvy
2018
false
false
false
France
French
Heterocyclic Compounds, 4 or More Rings
drug combinations
tenofovir alafenamide
emtricitabine, tenofovir alafenamide and bictegravir
hiv infections
adult
administration, oral
HIV integrase inhibitors
anti-hiv agents
reverse transcriptase inhibitors
aged
treatment outcome
bictegravir
evaluation of the transparency committee
Tenofovir
Emtricitabine
adenine
tenofovir alafenamide
bictegravir, emtricitabine, tenofovir alafenamide, drug combination

---
https://www.has-sante.fr/portail/jcms/c_2863577/fr/symtuza
2018
false
false
false
France
French
drug combinations
treatment outcome
anti-hiv agents
hiv infections
adult
adolescent
administration, oral
Cytochrome P-450 CYP3A Inhibitors
hiv protease inhibitors
reverse transcriptase inhibitors
antivirals for systemic use
evaluation of the transparency committee
insurance, health, reimbursement
Tenofovir
Darunavir
Cobicistat
tenofovir alafenamide
Emtricitabine
tenofovir alafenamide
adenine
Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate

---
https://www.has-sante.fr/portail/jcms/c_2847939/fr/vemlidy
2018
false
false
false
France
French
antiviral agents
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
aged
evaluation of the transparency committee
insurance, health, reimbursement
tenofovir alafenamide
tenofovir alafenamide
adenine

---
https://www.ema.europa.eu/medicines/human/EPAR/Symtuza
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
Darunavir
Cobicistat
drug approval
europe
treatment outcome
Emtricitabine
tenofovir alafenamide
anti-hiv agents
anti-hiv agents
hiv infections
product surveillance, postmarketing
adult
adolescent
administration, oral
tablets
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
hiv protease inhibitors
hiv protease inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
tenofovir alafenamide
antivirals for systemic use
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Tenofovir
Darunavir
Cobicistat
tenofovir alafenamide
Emtricitabine
tenofovir alafenamide
adenine
Darunavir Ethanolate/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate

---
https://www.ema.europa.eu/medicines/human/EPAR/Vemlidy
2017
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
tenofovir alafenamide
tenofovir alafenamide
antiviral agents
antiviral agents
drug approval
europe
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
tenofovir alafenamide
tenofovir alafenamide
adenine

---
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya
http://www.has-sante.fr/portail/jcms/c_2621468/fr/genvoya-emtricitabine-cobicistat-elvitegravir-et-tenofovir-alafenamide-association-d-antiviraux
2016
false
false
false
France
French
treatment outcome
drug combinations
tenofovir alafenamide
elvitegravir
hiv infections
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
HIV integrase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Emtricitabine
evaluation of the transparency committee
guidelines for drug use
tenofovir alafenamide
elvitegravir
adenine
adenine
quinolones

---
http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey
http://www.has-sante.fr/portail/jcms/c_2732128/fr/odefsey-emtricitabine-rilpivirine-tenofovir-alafenamide-association-d-antiretroviraux
2016
false
false
false
France
French
evaluation of the transparency committee
tenofovir alafenamide
tenofovir alafenamide
guidelines for drug use
administration, oral
treatment outcome
insurance, health, reimbursement
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
hiv infections
emtricitabine, tenofovir alafenamide and rilpivirine
adult
adolescent
human immunodeficiency virus i infection
HIV-1
Emtricitabine
Emtricitabine
Rilpivirine Hydrochloride
Rilpivirine Hydrochloride
tenofovir alafenamide
tenofovir alafenamide
adenine
adenine
adenine
Rilpivirine
Rilpivirine

---
https://www.ema.europa.eu/medicines/human/EPAR/Odefsey
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
emtricitabine, tenofovir alafenamide and rilpivirine
drug approval
europe
treatment outcome
Emtricitabine
Rilpivirine
tenofovir alafenamide
tenofovir alafenamide
drug combinations
product surveillance, postmarketing
adult
adolescent
hiv infections
HIV-1
human immunodeficiency virus i infection
administration, oral
reverse transcriptase inhibitors
reverse transcriptase inhibitors
anti-hiv agents
anti-hiv agents
prodrugs
risk assessment
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Rilpivirine Hydrochloride
Rilpivirine Hydrochloride
tenofovir alafenamide
Tenofovir
Emtricitabine
Rilpivirine
tenofovir alafenamide
adenine

---
https://www.ema.europa.eu/medicines/human/EPAR/Genvoya
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
tenofovir alafenamide
tenofovir alafenamide
elvitegravir
elvitegravir
hiv infections
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
drug evaluation, preclinical
anti-hiv agents
anti-hiv agents
adult
adolescent
human immunodeficiency virus i infection
administration, oral
Substance with integrase strand transfer inhibitor mechanism of action (substance)
HIV integrase inhibitors
HIV integrase inhibitors
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 CYP3A Inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
Cobicistat
Cobicistat
Emtricitabine
Emtricitabine
tenofovir alafenamide
tenofovir alafenamide
elvitegravir
elvitegravir
adenine
adenine
adenine
quinolones
quinolones

---